{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:42:11Z","timestamp":1773416531130,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T00:00:00Z","timestamp":1434499200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10875-015-0174-0","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T01:46:34Z","timestamp":1434419194000},"page":"449-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["IL2RG Reversion Event in a Common Lymphoid Progenitor Leads to Delayed Diagnosis and Milder Phenotype"],"prefix":"10.1007","volume":"35","author":[{"given":"Amy P.","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy P.","family":"Rump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulbu","family":"Uzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Puck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,17]]},"reference":[{"issue":"5","key":"174_CR1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jmii.2012.06.003","volume":"46","author":"MY Hsieh","year":"2013","unstructured":"Hsieh MY, Hong WH, Lin JJ, Lee WI, Lin KL, Wang HS, et al. T-cell receptor excision circles and repertoire diversity in children with profound T-cell immunodeficiency. J Microbiol Immunol Infect. 2013;46(5):374\u201381.","journal-title":"J Microbiol Immunol Infect"},{"key":"174_CR2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.01.032","volume":"129","author":"JM Puck","year":"2012","unstructured":"Puck JM. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol. 2012;129:607\u201316.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"174_CR3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/hmg\/2.8.1099","volume":"2","author":"JM Puck","year":"1993","unstructured":"Puck JM, Deschenes SM, Porter JC, Dutra AS, Brown CJ, Willard HF, et al. The interleukin-2 receptor g chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet. 1993;2(8):1099\u2013104.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"174_CR4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0092-8674(93)90167-O","volume":"73","author":"M Noguchi","year":"1993","unstructured":"Noguchi M, Yi Huafang Y, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, et al. Interleukin-2 receptor g chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993;73(1):147\u201357.","journal-title":"Cell"},{"issue":"5141","key":"174_CR5","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.8266078","volume":"262","author":"SM Russell","year":"1993","unstructured":"Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science. 1993;262(5141):1880\u20133.","journal-title":"Science"},{"issue":"5141","key":"174_CR6","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1126\/science.8266077","volume":"262","author":"M Noguchi","year":"1993","unstructured":"Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science. 1993;262(5141):1877\u201380.","journal-title":"Science"},{"issue":"1","key":"174_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/intimm\/7.1.115","volume":"7","author":"Y Kimura","year":"1995","unstructured":"Kimura Y, Takeshita T, Kondo M, Ishii N, Nakamura M, Van Snick J, et al. Sharing of the IL-2 receptor gama chain with the functional IL-9 receptor complex. Int Immunol. 1995;7(1):115\u201320.","journal-title":"Int Immunol"},{"issue":"5","key":"174_CR8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/jlb.57.5.763","volume":"57","author":"JG Giri","year":"1995","unstructured":"Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol. 1995;57(5):763\u20136.","journal-title":"J Leukoc Biol"},{"issue":"27","key":"174_CR9","doi-asserted-by":"crossref","first-page":"8725","DOI":"10.1021\/bi0202023","volume":"41","author":"T Habib","year":"2002","unstructured":"Habib T, Senadheera S, Weinberg K, Kaushansky K. The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry. 2002;41(27):8725\u201331.","journal-title":"Biochemistry"},{"issue":"26","key":"174_CR10","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1182\/blood-2011-06-362533","volume":"118","author":"M Recher","year":"2011","unstructured":"Recher M, Berglund LJ, Avery DT, Cowan MJ, Gennery AR, Smart J, et al. IL-21 is the primary common g chain-binding cytokine required for human B-cell differentiation in vivo. Blood. 2011;118(26):6824\u201335.","journal-title":"Blood"},{"issue":"3","key":"174_CR11","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4049\/jimmunol.174.3.1213","volume":"174","author":"CA Vosshenrich","year":"2005","unstructured":"Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, et al. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation nof NK cell precursors and peripheral NK cells in vivo. J Immunol. 2005;174(3):1213\u201321.","journal-title":"J Immunol"},{"key":"174_CR12","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJM199611213352104","volume":"335","author":"S Volker","year":"1996","unstructured":"Volker S, Volker W, Le Deist F, Dirksen U, Broker B, Muller-Fleckenstein I, et al. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med. 1996;335:1563\u20137.","journal-title":"N Engl J Med"},{"issue":"10","key":"174_CR13","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2008-04-153361","volume":"112","author":"C Speckmann","year":"2008","unstructured":"Speckmann C, Pannicke U, Wiech E, Schwarz K, Fisch P, Friedrich W, et al. Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency. Blood. 2008;112(10):4090\u20137.","journal-title":"Blood"},{"issue":"4","key":"174_CR14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s10875-012-9684-1","volume":"32","author":"T Kawai","year":"2012","unstructured":"Kawai T, Saito M, Nishikomori R, Yasumi T, Izawa K, Murakami T, et al. Multiple reversions of an IL2RG mutation restore T cell function in an X-linked severe combined immunodeficiency patient. J Clin Immunol. 2012;32(4):690\u20137.","journal-title":"J Clin Immunol"},{"issue":"7","key":"174_CR15","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3324\/haematol.2012.077511","volume":"98","author":"TW Kuijpers","year":"2013","unstructured":"Kuijpers TW, van Leeuwen EM, Barendregt BH, Klarenbeek P, Aan de Kerk DJ, Baars PA, et al. A reversion of an IL2RG mutation in combined immunodeficiency providing competititive advantage to the majority of CD8+ T cells. Haematologica. 2013;98(7):1030\u20138.","journal-title":"Haematologica"},{"issue":"6","key":"174_CR16","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jaci.2013.02.038","volume":"131","author":"AP Hsu","year":"2013","unstructured":"Hsu AP, Sowerwine KJ, Lawrence MG, Davis J, Henderson CJ, Zarember KA, et al. Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism. J Allergy Clin Immunol. 2013;131(6):1586\u201393.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"174_CR17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1182\/blood-2007-04-082552","volume":"111","author":"G Uzel","year":"2008","unstructured":"Uzel G, Tng E, Rosenzweig SD, Hsu AP, Shaw JM, Horwitz ME, et al. Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood. 2008;111(1):209\u201318.","journal-title":"Blood"},{"issue":"7","key":"174_CR18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2014.9132","volume":"312","author":"A Kwan","year":"2014","unstructured":"Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for SCID in the United States: experience from 11 screening programs. JAMA. 2014;312(7):729\u201338.","journal-title":"JAMA"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-015-0174-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-015-0174-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-015-0174-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T01:22:05Z","timestamp":1566868925000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-015-0174-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,17]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1007\/s10875-015-0174-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,17]]}}}